Berkshire Health Systems
  • Coronavirus Information Kiosk
  • Berkshire Patient Portal
  • COVID-19 Relief Fund for Berkshire Health Systems
  • Pay Your Bill Online
  • About Us
  • Employment
  • Medical Staff Portal
  • Coronavirus Information Kiosk
  • Berkshire Patient Portal
  • BMC Parking Maps
  • Advocacy for Access
  • Berkshire Patient Portal
  • BHS Blood Drawing Stations
  • BHS Bloodmobile
  • BHS Community Benefits Implementation Plan
  • BHS News
  • BHS Privacy Practices
  • BMC Community Benefits Report FY 2018
  • Fairview Hospital FY 2018 Community Benefit Report
  • BMC Medical Interpreters
  • Community Outreach Program
  • County Health Needs Assessment
  • Financial Counseling/Ayuda Financiera
  • Helpful Patient Tools
  • Medical Interpreters at Fairview
  • MedlinePlus
  • MedlinePlus en Espanol
  • One Medical Passport
  • Pay Your Bill Online
  • Pre-Surgical Assessment
  • Request a Medical Record
  • Send a Patient Greeting
  • Wellness Works Website - For BHS Employees & Spouses
  • Worksite Wellness
Berkshire Health Systems
  • Programs & Services
    • Addiction Services
    • Anesthesiology
    • Bariatrics
    • Better Start
    • Cancer Care
    • Cardiology
    • Concussion
    • Diabetes Care
    • Emergency Care
    • Endoscopy
    • Healthy Steps
    • Home Care
    • Hospitalists
    • Kidney & Dialysis
    • Laboratory Services
    • Maternity
    • Neurology
    • Neurosurgery
    • Occupational Med
    • Orthopedics
    • Outreach
    • Pain Management
    • Pharmacy
    • Psychiatry
    • Pulmonary Care
    • Radiology
    • Rehabilitation
    • Sleep Disorders
    • Sports Medicine
    • Stroke Care
    • Surgery
    • Trauma Care
    • Travel Medicine
    • Urgent Care
    • Urology
    • Wellness
    • WIC Program
    • Women's Imaging
    • Wound Care
    • Patient & Visitor Information
    • Quality Care & Patient Safety
    • Calendar & Events
    • News
    • Maps & Directions
    • Ways to Give
    • Health Encyclopedia
    • Berkshire Medical Center, Pittsfield, MA
    • Fairview Hospital, Great Barrington, MA
    • Berkshire Visiting Nurse Association
    • BHS Survey Module
  • Locations
    • Berkshire Medical Center
    • Fairview Hospital
    • North Adams Campus of BMC
    • BMC & Fairview Physician Practices
    • Berkshire Visiting Nurse Association
    • BHS Urgent Care
    • Long Term Care
    • BHS Laboratory - Blood Drawing Stations
  • Find a Physician
  • BHS Physician Practices
  • Medical Education
    • Message from Dr. Alex Sabo
    • Internal Medicine Residency
    • Surgery Residency
    • Osteopathic Medical Education
    • Psychiatry Residency
    • Dentistry Residency
    • Medical Students
    • Continuing Medical Education
    • School of Medical Technology
    • Schwartz Center Rounds
  • Coronavirus Information Kiosk
  • Berkshire Patient Portal
  • COVID-19 Relief Fund for Berkshire Health Systems
  • Pay Your Bill Online
  • About Us
  • Employment
  • Medical Staff Portal
S1007 -
  1. Home
  2. Clinical Trials

Clinical Trials

Principal Name   Harvey ZImbler, MD
Contact Name   Gloria Gero
Phone   (413) 496-8205
Alternate Phone   (413) 443-6000
Fax   (413) 443-2203
Title   S1007 - " A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients iwth 1-3 Postiive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score of 25 or less"
Description   Primary Objective:
To determine the effect of chemotherapy in paitients with node positive breast cancer who do no have high Recurrence Scores (RS) by Oncotyp eDX. In patients with 1-3 positive nodes, and hormone receptor (HR) -positive, HER2-negative breast cancer with RS<25 treated with endocrine therapy we will test whether the difference in disease-free survival for patients treated with chemotherapy compared to no chemotherapy depends directly on the magnitude of RS. If benefit depends on the RS score, the trial will determine the optimal cutpoint for reommending chemotherapy or not.
Treatment   Oncology
Inclusion/Notes   ELIGIBILITY:
- Patient must have a histologically confirmed diagnosis of node positive (1-3nodes) invasive breast carcinoma iwth
positive ER and/or PR status. ER and PR positivity must be assessed according to ASCO/CAP guidelines. If HER2 IHC
is 2+, FISH/CISH must be performed and must not be positive (must be a ratio of <2.2)
- Patients with multifocal, multicentric and synchronous bilateral breast cancers are allowed.
- Patients will have undergone axillary stagine by sentinel node biopsy or axillary lymph nodes dissection (ALND). - - Patients must have at least one, but no more than three known positive lymph nodes (pN1mi, pN1a, pN1b or pN1c),.
- Patients with positive sentinel node are not required to undergo full axillary lymph node dissection., this is
at discretion of the treating physician.
- patients must not have inflmammatory breast cancer and must not have metastatic disease. Patients with a prior
- diagnosis of DCIS are eligible if they received mastectomy alone. Radiation in the opposite breast is acceptable.

- Patients must have had either breast -conserving surgery iwht planned rT ir titak nastectint, Oatuebts nyst gave ckear a=nargubs,
' -Registration of patient swho have not yet undergone Oncotype DX screenign must occur no later than 56 days after definitive surgery.
- P{atients must be females > 18 years of age.
- Patients must have a PS of 0-2 by Zubrod criteria
Patients mustw not have begun chemotherapy or endocrine therapy for their breast cancer prior to registration
- Patients must not have received preventive tamoxifgen or raloxifene for prevention of breast cancer, or have received prior therapeutic ipsilateral obrast radiation, unless it partial breast irradiation for the index tumor.
- Patients must nob e pregnannt or nursing due to possibility of harm to fetur or nursing infant from this treatment regimen.
- No other prior malignancy is allowed excpet fo the foolwing, adequately treated basal cell or squamous cell skin cancer, in situcervical cancer, adquatly treated Stage 0,1 or II cancer from which the patient si currently in complete remisison, or any ohter cancer from which te paatient has been disease-free for 5 years.
- All patient must be informed of the invetigational nature of theis study and must sign and give written informed consent.
Status   accruing
Current Trial Type   treatment
  •   (413) 447-2000
  •   Email - General Inquiries Only
  •   Email - BMC Patient Experience
  •   Email - BHS Physician Practices
  •   Email - Fairview Hospital Inquiries
  • Employment at BHS
  • About Us
  • 2018 BMC Report on Cancer
  • Quality Care & Patient Safety
  • Berkshire Patient Portal
  • Awards & Accreditations
  • BHS Community Outreach
  • BHS Bloodmobile
  • BMC FY 2018 Community Benefits Report
  • Fairview FY 2018 Community Benefits Report
  • Ways to Give
  • Give Us Your Feedback

© 2021 Berkshire Health Systems

725 North Street

Pittsfield, MA 01201

  • News
  • Privacy Practices
  • Practicas De Privacidad
  • Site Map
  • BHS Privacy Practices
  • Contact Us